More than a decade after its introduction, the research and development tax incentive has been “life-changing” for Australia’s biotech industry and an example of how effective long-term consistent policy...
Helping companies see the benefit of being commonly understood is the essence of ensuring a comparable environmental, social and governance (ESG) practice for biotechs and medtechs. This provided the...